Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1956 1
1957 1
1958 1
1961 3
1962 4
1963 3
1965 2
1966 2
1968 8
1969 6
1970 4
1971 4
1972 8
1973 1
1974 12
1975 3
1976 16
1977 7
1978 8
1979 12
1980 4
1981 7
1982 4
1983 11
1984 15
1985 16
1986 9
1987 14
1988 14
1989 19
1990 12
1991 16
1992 18
1993 17
1994 16
1995 18
1996 16
1997 18
1998 20
1999 23
2000 23
2001 17
2002 22
2003 23
2004 21
2005 28
2006 33
2007 42
2008 27
2009 39
2010 39
2011 41
2012 52
2013 59
2014 48
2015 46
2016 64
2017 81
2018 70
2019 76
2020 109
2021 114
2022 7
Text availability
Article attribute
Article type
Publication date

Search Results

1,339 results
Results by year
Filters applied: . Clear all
Page 1
Gut Microbiota and Chronic Constipation: A Review and Update.
Ohkusa T, Koido S, Nishikawa Y, Sato N. Ohkusa T, et al. Among authors: nishikawa y. Front Med (Lausanne). 2019 Feb 12;6:19. doi: 10.3389/fmed.2019.00019. eCollection 2019. Front Med (Lausanne). 2019. PMID: 30809523 Free PMC article. Review.
Age-related remodelling of oesophageal epithelia by mutated cancer drivers.
Yokoyama A, Kakiuchi N, Yoshizato T, Nannya Y, Suzuki H, Takeuchi Y, Shiozawa Y, Sato Y, Aoki K, Kim SK, Fujii Y, Yoshida K, Kataoka K, Nakagawa MM, Inoue Y, Hirano T, Shiraishi Y, Chiba K, Tanaka H, Sanada M, Nishikawa Y, Amanuma Y, Ohashi S, Aoyama I, Horimatsu T, Miyamoto S, Tsunoda S, Sakai Y, Narahara M, Brown JB, Sato Y, Sawada G, Mimori K, Minamiguchi S, Haga H, Seno H, Miyano S, Makishima H, Muto M, Ogawa S. Yokoyama A, et al. Among authors: nishikawa y. Nature. 2019 Jan;565(7739):312-317. doi: 10.1038/s41586-018-0811-x. Epub 2019 Jan 2. Nature. 2019. PMID: 30602793
Identification of an Anti-Integrin αvβ6 Autoantibody in Patients With Ulcerative Colitis.
Kuwada T, Shiokawa M, Kodama Y, Ota S, Kakiuchi N, Nannya Y, Yamazaki H, Yoshida H, Nakamura T, Matsumoto S, Muramoto Y, Yamamoto S, Honzawa Y, Kuriyama K, Okamoto K, Hirano T, Okada H, Marui S, Sogabe Y, Morita T, Matsumori T, Mima A, Nishikawa Y, Ueda T, Matsumura K, Uza N, Chiba T, Seno H. Kuwada T, et al. Among authors: nishikawa y. Gastroenterology. 2021 Jun;160(7):2383-2394.e21. doi: 10.1053/j.gastro.2021.02.019. Epub 2021 Feb 12. Gastroenterology. 2021. PMID: 33582126 Free article.
Advance care planning for adults with heart failure.
Nishikawa Y, Hiroyama N, Fukahori H, Ota E, Mizuno A, Miyashita M, Yoneoka D, Kwong JS. Nishikawa Y, et al. Cochrane Database Syst Rev. 2020 Feb 27;2(2):CD013022. doi: 10.1002/14651858.CD013022.pub2. Cochrane Database Syst Rev. 2020. PMID: 32104908 Free PMC article.
ARF6 and AMAP1 are major targets of KRAS and TP53 mutations to promote invasion, PD-L1 dynamics, and immune evasion of pancreatic cancer.
Hashimoto S, Furukawa S, Hashimoto A, Tsutaho A, Fukao A, Sakamura Y, Parajuli G, Onodera Y, Otsuka Y, Handa H, Oikawa T, Hata S, Nishikawa Y, Mizukami Y, Kodama Y, Murakami M, Fujiwara T, Hirano S, Sabe H. Hashimoto S, et al. Among authors: nishikawa y. Proc Natl Acad Sci U S A. 2019 Aug 27;116(35):17450-17459. doi: 10.1073/pnas.1901765116. Epub 2019 Aug 9. Proc Natl Acad Sci U S A. 2019. PMID: 31399545 Free PMC article.
MBC2019: Marine Biotechnology Conference 2019.
Takeyama H, Saito H, Nishikawa Y. Takeyama H, et al. Among authors: nishikawa y. Mar Biotechnol (NY). 2020 Dec;22(6):725-726. doi: 10.1007/s10126-020-10009-0. Mar Biotechnol (NY). 2020. PMID: 33244657 No abstract available.
Response to commentary by Kageura et al.
Sawano T, Takita M, Senoo Y, Nishikawa Y, Crump A, Tsubokura M. Sawano T, et al. Among authors: nishikawa y. QJM. 2022 Jan 9;114(12):903. doi: 10.1093/qjmed/hcab082. QJM. 2022. PMID: 33904570 No abstract available.
Acupuncture for Cancer Survivors.
Oura M, Omata F, Nishikawa Y. Oura M, et al. Among authors: nishikawa y. JAMA Oncol. 2021 Sep 1;7(9):1399-1400. doi: 10.1001/jamaoncol.2021.2517. JAMA Oncol. 2021. PMID: 34323934 No abstract available.
Dipeptidyl peptidase-4 inhibitors, glucagon-like peptide 1 receptor agonists and sodium-glucose co-transporter-2 inhibitors for people with cardiovascular disease: a network meta-analysis.
Kanie T, Mizuno A, Takaoka Y, Suzuki T, Yoneoka D, Nishikawa Y, Tam WWS, Morze J, Rynkiewicz A, Xin Y, Wu O, Providencia R, Kwong JS. Kanie T, et al. Among authors: nishikawa y. Cochrane Database Syst Rev. 2021 Oct 25;10:CD013650. doi: 10.1002/14651858.CD013650.pub2. Cochrane Database Syst Rev. 2021. PMID: 34693515
1,339 results